{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:46:01Z","timestamp":1770515161291,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s43440-024-00691-5","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T11:06:54Z","timestamp":1740481614000},"page":"729-738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of 3,5,4\u2032-tri-[4-(nitrooxy)butanoyl]oxy resveratrol, a new nitric oxide-releasing derivative of resveratrol, on platelet activation"],"prefix":"10.1007","volume":"77","author":[{"given":"Giuseppe","family":"Guglielmini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Berardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carla","family":"Marcotullio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Gresele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"691_CR1","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/0140-6736(92)91277-f","volume":"339","author":"S Renaud","year":"1992","unstructured":"Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992;339:1523\u20136. https:\/\/doi.org\/10.1016\/0140-6736(92)91277-f.","journal-title":"Lancet"},{"key":"691_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd2060","volume":"5","author":"JA Baur","year":"2006","unstructured":"Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5:493\u2013506. https:\/\/doi.org\/10.1038\/nrd2060.","journal-title":"Nat Rev Drug Discov"},{"key":"691_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/mnfr.201200589","volume":"58","author":"CH Cottart","year":"2014","unstructured":"Cottart CH, Nivet-Antoine V, Beaudeux JL. Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans. Mol Nutr Food Res. 2014;58:7\u201321. https:\/\/doi.org\/10.1002\/mnfr.201200589.","journal-title":"Mol Nutr Food Res"},{"key":"691_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mam.2004.09.003","volume":"26","author":"KM Naseem","year":"2005","unstructured":"Naseem KM. The role of nitric oxide in cardiovascular diseases. Mol Aspects Med. 2005;26:33\u201365. https:\/\/doi.org\/10.1016\/j.mam.2004.09.003.","journal-title":"Mol Aspects Med"},{"key":"691_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jnutbio.2010.07.004","volume":"22","author":"P Gresele","year":"2011","unstructured":"Gresele P, Cerletti C, Guglielmini G, Pignatelli P, de Gaetano G, Violi F. Effects of resveratrol and other wine polyphenols on vascular function: an update. J Nutr Biochem. 2011;22:201\u201311. https:\/\/doi.org\/10.1016\/j.jnutbio.2010.07.004.","journal-title":"J Nutr Biochem"},{"key":"691_CR6","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/0140-6736(93)92472-6","volume":"341","author":"EN Frankel","year":"1993","unstructured":"Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet. 1993;341:1103\u20134. https:\/\/doi.org\/10.1016\/0140-6736(93)92472-6.","journal-title":"Lancet"},{"key":"691_CR7","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/10715760290029083","volume":"36","author":"P Brito","year":"2002","unstructured":"Brito P, Almeida LM, Dinis TCP. The interaction of resveratrol with ferrylmyoglobin and peroxynitrite; protection against LDL oxidation. Free Radic Res. 2002;36:621\u201331. https:\/\/doi.org\/10.1080\/10715760290029083.","journal-title":"Free Radic Res"},{"key":"691_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejphar.2004.02.031","volume":"489","author":"Z Cao","year":"2004","unstructured":"Cao Z, Li Y. Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur J Pharmacol. 2004;489:39\u201348. https:\/\/doi.org\/10.1016\/j.ejphar.2004.02.031.","journal-title":"Eur J Pharmacol"},{"key":"691_CR9","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/sj.bjp.0701784","volume":"123","author":"S Rotondo","year":"1998","unstructured":"Rotondo S, Rajtar G, Manarini S, Celardo A, Rotilio D, De Gaetano G, et al. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol. 1998;123:1691\u20139. https:\/\/doi.org\/10.1038\/sj.bjp.0701784.","journal-title":"Br J Pharmacol"},{"key":"691_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1124\/jpet.110.168724","volume":"335","author":"N Xia","year":"2010","unstructured":"Xia N, Daiber A, Habermeier A, Closs EI, Thum T, Spanier G, et al. Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice. J Pharmacol Exp Ther. 2010;335:149\u201354. https:\/\/doi.org\/10.1124\/jpet.110.168724.","journal-title":"J Pharmacol Exp Ther"},{"key":"691_CR11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1440-1681.2010.05368.x","volume":"37","author":"Q Yuan","year":"2010","unstructured":"Yuan Q, Peng J, Liu SY, Wang CJ, Xiang DX, Xiong XM, et al. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase\/asymmetric dimethylarginine pathway. Clin Exp Pharmacol Physiol. 2010;37:630\u20135. https:\/\/doi.org\/10.1111\/j.1440-1681.2010.05368.x.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"691_CR12","doi-asserted-by":"publisher","first-page":"H634","DOI":"10.1152\/ajpheart.01315.2010","volume":"301","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Janssens SP, Wingler K, Schmidt HHHW, Moens AL. Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy. Am J Physiol Heart Circ Physiol. 2011;301:H634\u201346. https:\/\/doi.org\/10.1152\/ajpheart.01315.2010.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"691_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbrc.2010.01.080","volume":"393","author":"G Arunachalam","year":"2010","unstructured":"Arunachalam G, Yao H, Sundar IK, Caito S, Rahman I. SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: role of resveratrol. Biochem Biophys Res Commun. 2010;393:66\u201372. https:\/\/doi.org\/10.1016\/j.bbrc.2010.01.080.","journal-title":"Biochem Biophys Res Commun"},{"key":"691_CR14","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.mehy.2008.06.031","volume":"71","author":"L Tan","year":"2008","unstructured":"Tan L, Yu JT, Guan HS. Resveratrol exerts pharmacological preconditioning by activating PGC-1alpha. Med Hypotheses. 2008;71:664\u20137. https:\/\/doi.org\/10.1016\/j.mehy.2008.06.031.","journal-title":"Med Hypotheses"},{"key":"691_CR15","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/mnfr.200500010","volume":"49","author":"E Wenzel","year":"2005","unstructured":"Wenzel E, Somoza V. Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res. 2005;49:472\u201381. https:\/\/doi.org\/10.1002\/mnfr.200500010.","journal-title":"Mol Nutr Food Res"},{"key":"691_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2007.05.014","volume":"570","author":"S Momi","year":"2007","unstructured":"Momi S, Impagnatiello F, Guzzetta M, Caracchini R, Guglielmini G, Olivieri R, et al. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. Eur J Pharmacol. 2007;570:115\u201324. https:\/\/doi.org\/10.1016\/j.ejphar.2007.05.014.","journal-title":"Eur J Pharmacol"},{"key":"691_CR17","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/hc0502.104540","volume":"105","author":"S Verma","year":"2002","unstructured":"Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation. 2002;105:546\u20139. https:\/\/doi.org\/10.1161\/hc0502.104540.","journal-title":"Circulation"},{"key":"691_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00418-004-0675-z","volume":"122","author":"B Voetsch","year":"2004","unstructured":"Voetsch B, Jin RC, Loscalzo J. Nitric oxide insufficiency and atherothrombosis. Histochem Cell Biol. 2004;122:353\u201367. https:\/\/doi.org\/10.1007\/s00418-004-0675-z.","journal-title":"Histochem Cell Biol"},{"key":"691_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1021\/ml300002m","volume":"3","author":"R Kodela","year":"2012","unstructured":"Kodela R, Chattopadhyay M, Kashfi K. NOSH-Aspirin: a ovel nitric oxide-hydrogen sulfide-releasing hybrid: a new class of anti-inflammatory pharmaceuticals. ACS Med Chem Lett. 2012;3:257\u201362. https:\/\/doi.org\/10.1021\/ml300002m.","journal-title":"ACS Med Chem Lett"},{"key":"691_CR20","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1016\/j.bmc.2005.07.049","volume":"13","author":"GN Ziakas","year":"2005","unstructured":"Ziakas GN, Rekka EA, Gavalas AM, Eleftheriou PT, Tsiakitzis KC, Kourounakis PN. Nitric oxide releasing derivatives of tolfenamic acid with anti-inflammatory activity and safe gastrointestinal profile. Bioorg Med Chem. 2005;13:6485\u201392. https:\/\/doi.org\/10.1016\/j.bmc.2005.07.049.","journal-title":"Bioorg Med Chem"},{"key":"691_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1365-2141.1972.tb08800.x","volume":"22","author":"JF Mustard","year":"1972","unstructured":"Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspensions of washed platelets from humans. Br J Haematol. 1972;22:193\u2013204. https:\/\/doi.org\/10.1111\/j.1365-2141.1972.tb08800.x.","journal-title":"Br J Haematol"},{"key":"691_CR22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.fitote.2015.07.009","volume":"105","author":"F Messina","year":"2015","unstructured":"Messina F, Guglielmini G, Curini M, Orsini S, Gresele P, Marcotullio MC. Effect of substituted stilbenes on platelet function. Fitoterapia. 2015;105:228\u201333. https:\/\/doi.org\/10.1016\/j.fitote.2015.07.009.","journal-title":"Fitoterapia"},{"key":"691_CR23","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/s0049-3848(98)00159-5","volume":"92","author":"JJ Sixma","year":"1998","unstructured":"Sixma JJ, de Groot PG, van Zanten H, IIJsseldijk M. A new perfusion chamber to detect platelet adhesion using a small volume of blood. Thromb Res. 1998;92:S43\u20136. https:\/\/doi.org\/10.1016\/s0049-3848(98)00159-5.","journal-title":"Thromb Res"},{"key":"691_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1160\/th15-04-0300","volume":"115","author":"G Guglielmini","year":"2016","unstructured":"Guglielmini G, Appolloni V, Momi S, De Groot PG, Battiston M, De Marco L, la. Matrix metalloproteinase-2 enhances platelet deposition on collagen under flow conditions. Thromb Haemost. 2016;115:333\u201343. https:\/\/doi.org\/10.1160\/th15-04-0300.","journal-title":"Thromb Haemost"},{"key":"691_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-60761-411-1_4","volume-title":"Advanced protocols in oxidative stress II","author":"E Eruslanov","year":"2010","unstructured":"Eruslanov E, Kusmartsev S. Identification of ROS using oxidized DCFDA and flow-cytometry. In: Armstrong D, editor. Advanced protocols in oxidative stress II. Totowa: Humana Press; 2010. p. 57\u201372."},{"key":"691_CR26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1160\/th09-01-0057","volume":"102","author":"M Crescente","year":"2009","unstructured":"Crescente M, Jessen G, Momi S, H\u00f6ltje HD, Gresele P, Cerletti C, et al. Interactions of gallic acid, resveratrol, quercetin and aspirin at the platelet cyclooxygenase-1 level. Functional and modelling studies. Thromb Haemost. 2009;102:336\u201346. https:\/\/doi.org\/10.1160\/th09-01-0057.","journal-title":"Thromb Haemost"},{"key":"691_CR27","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1161\/atvbaha.114.303290","volume":"34","author":"S Momi","year":"2014","unstructured":"Momi S, Caracchini R, Falcinelli E, Evangelista S, Gresele P. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis. Arterioscler Thromb Vasc Biol. 2014;34:820\u20139. https:\/\/doi.org\/10.1161\/atvbaha.114.303290.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"691_CR28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1160\/TH13-10-0818","volume":"111","author":"F Violi","year":"2014","unstructured":"Violi F, Pignatelli P. Platelet NOX, a novel target for anti-thrombotic treatment. Thromb Haemost. 2014;111:817\u201323. https:\/\/doi.org\/10.1160\/TH13-10-0818.","journal-title":"Thromb Haemost"},{"key":"691_CR29","first-page":"e134","volume":"15","author":"B Juhasz","year":"2010","unstructured":"Juhasz B, Mukherjee S, Das DK. Hormetic response of resveratrol against cardioprotection. Exp Clin Cardiol. 2010;15:e134-138.","journal-title":"Exp Clin Cardiol"},{"key":"691_CR30","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/jn\/138.9.1602","volume":"138","author":"P Gresele","year":"2008","unstructured":"Gresele P, Pignatelli P, Guglielmini G, Carnevale R, Mezzasoma AM, Ghiselli A, et al. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J Nutr. 2008;138:1602\u20138. https:\/\/doi.org\/10.1093\/jn\/138.9.1602.","journal-title":"J Nutr"},{"key":"691_CR31","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1161\/01.cir.0000034445.31543.43","volume":"106","author":"JF Leikert","year":"2002","unstructured":"Leikert JF, R\u00e4thel TR, Wohlfart P, Cheynier V, Vollmar AM, Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation. 2002;106:1614\u20137. https:\/\/doi.org\/10.1161\/01.cir.0000034445.31543.43.","journal-title":"Circulation"},{"key":"691_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00592-013-0480-z","volume":"51","author":"F Raffaelli","year":"2013","unstructured":"Raffaelli F, Vignini A, Giulietti A, Alidori A, Borroni F, Sforza G, et al. In vitro effects of resveratrol on oxidative stress in diabetic platelets. Acta Diabetol. 2013;51:61\u20139. https:\/\/doi.org\/10.1007\/s00592-013-0480-z.","journal-title":"Acta Diabetol"},{"key":"691_CR33","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1365-2141.2007.06788.x","volume":"139","author":"MY Shen","year":"2007","unstructured":"Shen MY, Hsiao G, Liu CL, Fong TH, Lin KH, Chou DS, et al. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO\/cyclic GMP. Br J Haematol. 2007;139:475\u201385. https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06788.x.","journal-title":"Br J Haematol"},{"key":"691_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1527-3466.2006.00148.x","volume":"24","author":"P Gresele","year":"2006","unstructured":"Gresele P, Momi S. Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders. Cardiovasc Drug Rev. 2006;24:148\u201368. https:\/\/doi.org\/10.1111\/j.1527-3466.2006.00148.x.","journal-title":"Cardiovasc Drug Rev"},{"key":"691_CR35","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/cvr\/cvs100","volume":"94","author":"S Momi","year":"2012","unstructured":"Momi S, Monopoli A, Alberti PF, Falcinelli E, Corazzi T, Conti V, et al. Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. Cardiovasc Res. 2012;94:428\u201338. https:\/\/doi.org\/10.1093\/cvr\/cvs100.","journal-title":"Cardiovasc Res"},{"key":"691_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.bcp.2019.05.030","volume":"166","author":"P Gresele","year":"2019","unstructured":"Gresele P, Momi S, Guglielmini G. Nitric oxide-enhancing or -releasing agents as antithrombotic drugs. Biochem Pharmacol. 2019;166:300\u201312. https:\/\/doi.org\/10.1016\/j.bcp.2019.05.030.","journal-title":"Biochem Pharmacol"},{"key":"691_CR37","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1080\/17460441.2017.1344400","volume":"12","author":"RAM Serafim","year":"2017","unstructured":"Serafim RAM, Pernichelle FG, Ferreira EI. The latest advances in the discovery of nitric oxide hybrid drug compounds. Expert Opin Drug Discov. 2017;12:941\u201353. https:\/\/doi.org\/10.1080\/17460441.2017.1344400.","journal-title":"Expert Opin Drug Discov"},{"key":"691_CR38","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.jvs.2012.05.064","volume":"56","author":"P Gresele","year":"2012","unstructured":"Gresele P, Migliacci R, Arosio E, Bonizzoni E, Minuz P, Violi F. Effect on walking distance and atherosclerosis progression of a nitric oxide-donating agent in intermittent claudication. J Vasc Surg. 2012;56:1622\u20138. https:\/\/doi.org\/10.1016\/j.jvs.2012.05.064.","journal-title":"J Vasc Surg"},{"key":"691_CR39","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1160\/TH06-10-0555","volume":"97","author":"P Gresele","year":"2007","unstructured":"Gresele P, Migliacci R, Procacci A, De Monte P, Bonizzoni E. Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication. Thromb Haemost. 2007;97:444\u201350. https:\/\/doi.org\/10.1160\/TH06-10-0555.","journal-title":"Thromb Haemost"},{"key":"691_CR40","doi-asserted-by":"publisher","first-page":"8497","DOI":"10.1073\/pnas.0401996101","volume":"101","author":"E Ongini","year":"2004","unstructured":"Ongini E, Impagnatiello F, Bonazzi A, Guzzetta M, Govoni M, Monopoli A, et al. Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties. Proc Natl Acad Sci U S A. 2004;101:8497\u2013502. https:\/\/doi.org\/10.1073\/pnas.0401996101.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"691_CR41","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.tips.2008.05.002","volume":"29","author":"P Gresele","year":"2008","unstructured":"Gresele P, Falcinelli E, Momi S. Potentiation and priming of platelet activation: a potential target for antiplatelet therapy. Trends Pharmacol Sci. 2008;29:352\u201360. https:\/\/doi.org\/10.1016\/j.tips.2008.05.002.","journal-title":"Trends Pharmacol Sci"},{"key":"691_CR42","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1161\/hh0801.089861","volume":"88","author":"J Loscalzo","year":"2001","unstructured":"Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res. 2001;88:756\u201362. https:\/\/doi.org\/10.1161\/hh0801.089861.","journal-title":"Circ Res"},{"key":"691_CR43","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.bmcl.2017.04.007","volume":"27","author":"LA Dutra","year":"2017","unstructured":"Dutra LA, Guanaes JFO, Johmann N, Lopes Pires ME, Chin CM, Marcondes S, et al. Synthesis, antiplatelet and antithrombotic activities of resveratrol derivatives with NO-donor properties. Bioorg Med Chem Lett. 2017;27:2450\u20133. https:\/\/doi.org\/10.1016\/j.bmcl.2017.04.007.","journal-title":"Bioorg Med Chem Lett"},{"key":"691_CR44","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1126\/science.1281928","volume":"258","author":"JS Stamler","year":"1992","unstructured":"Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 1992;258:1898\u2013902. https:\/\/doi.org\/10.1126\/science.1281928.","journal-title":"Science"},{"key":"691_CR45","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2174\/1568026054679335","volume":"5","author":"M Bolla","year":"2005","unstructured":"Bolla M, Almirante N, Benedini F. Therapeutic potential of nitrate esters of commonly used drugs. Curr Top Med Chem. 2005;5:707\u201320. https:\/\/doi.org\/10.2174\/1568026054679335.","journal-title":"Curr Top Med Chem"},{"key":"691_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115297","volume":"206","author":"P Gresele","year":"2022","unstructured":"Gresele P, Momi S. Novel approaches to antiplatelet therapy. Biochem Pharmacol. 2022;206: 115297. https:\/\/doi.org\/10.1016\/j.bcp.2022.115297.","journal-title":"Biochem Pharmacol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-024-00691-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-024-00691-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-024-00691-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T13:11:16Z","timestamp":1747055476000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-024-00691-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["691"],"URL":"https:\/\/doi.org\/10.1007\/s43440-024-00691-5","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}